Bovine mammary epithelial (BME-UV1, clone E-T and BME-UV, clone E-T2) and myoepithelial (BMM-UV, clone m-T2) cell lines were used to study the modulation of cell-associated activity of urokinase-type plasminogen activator (u-PA), as well as mRNA transcripts of u-PA, its receptor (u-PAR), and inhibitors (PAI-1 and PAI-2) during the cell cycle. After release from a growth arrest accomplished by growth factor deprivation, the length of the cell cycle was determined as 19^21 h, with G 1 , S, and G 2 +M phases of 6^7, 7^9, and 5^6 h respectively. As the cell cycle progressed, accumulated cell-associated u-PA activity increased. Maximal activity occurred at the S/G 2 boundary and decreased during the G 2 /M phases. All cell lines tested produced plasmin-specific inhibitor(s). Accumulation of u-PA mRNA peaked 3 h after stimulation into the growth cycle for m-T2 and E-T and during 3^6 h for E-T2 cells. Maximum levels of u-PAR mRNA were observed at 3 h for the E-T cell line, 6^9 h for E-T2 cells, and 3^9 h for m-T2 cells. The cell cycle distribution of the PAI-1 mRNA was similar to that of u-PA for both epithelial cell lines, while for m-T2 cells maximal accumulation of PAI-1 mRNA was detected at 3^9 h after growth initiation. The increase of PAI-2 mRNA transcription for m-T2 and E-T cells was detected at 3^6 h. The PAI-2 mRNA in E-T2 cells was under detectable levels. The data indicate that the expression of the constituents of the PA system in bovine mammary epithelial and myoepithelial cells is not cell type-dependent but is tightly connected to the phase of the cell cycle. z 1998 Elsevier Science B.V.
Introduction
Urokinase-type plasminogen activator (u-PA) is a speci¢c serine protease expressed by many mammalian cells [1] . While its major feature is to convert inactive plasminogen into the active enzyme, plasmin [2, 3] , u-PA can also directly degrade some extracellular matrix proteins [4] . Plasmin, which is also a serine protease with a broader spectrum of speci¢city than that of u-PA, can degrade the extracellular matrix directly or indirectly by activating a broad range of latent metalloproteinases [5] . Signi¢cant attention has been paid to plasminogen activators because of their importance in a wide variety of biological processes including tissue remodeling, wound healing, cell migration, tumor invasion and metastasis, and extracellular matrix turnover (for review see [2, 3, 5, 6] ). It is widely accepted that the production of u-PA is regulated by growth factors [7, 8] , hormones [9, 10] , extracellular matrix proteins [10] , retinoic acid [11] , and even some bacterial products [12, 13] . The activity of u-PA in vivo is directed and controlled by a speci¢c u-PA receptor (u-PAR) and by a network of PA-speci¢c inhibitors including PAI-1, PAI-2, protease nexin (PN-1), and PAI-3 (protein C inhibitor). u-PAR expression in di¡erent cell types is also highly regulated in a manner similar to that of u-PA [14] . As is the case with PA and u-PAR, the PAI are secreted by speci¢c cell types in a highly regulated manner and were found to be expressed at invasive foci in many types of tumors as well as by di¡erent normal and established cell types [15] . Finally, plasmin activity is also modulated by numerous plasminspeci¢c inhibitors (K 2 -antiplasmin, K 2 -macroglobulin, protease nexin, and urinary trypsin inhibitor/bikunin) synthesized by the liver and other tissues [1, 5, 6, 16] . Since the PA/plasminogen system is implicated in a variety of basic biological processes, the physiological, biochemical, enzymological, and biophysical characteristics of the di¡erent components of this system have been extensively studied during the last decade.
Less attention has been given to the role of the plasminogen activator system during the cell cycle. Recently, Ryan et al. [16] have reported that in synchronized normal rat kidney cells, accumulation of PAI-1 transcript peaked in mid-G 1 phase and declined during the S phase of the cell cycle. Similar regulation of PAI-1 mRNA transcription has been shown for synchronized human epidermal keratinocytes [17] . Orfanoudakis et al. [18] and Aggeler et al. [19] , using di¡erent cell models, found that the highest level of cell-associated PA activity occurred during S/G 2 transition and was greatly reduced during G 2 /M. This suggests that PA may be involved in DNA replication and/or cell division. To our knowledge, no comprehensive studies have investigated the kinetics of cell cycle-dependent changes in PA activity along with modulation of corresponding mRNA transcripts.
We have previously reported that bovine mammary cells in culture express u-PA, u-PAR, and PAI-1 [20, 21] . Here we demonstrate that the modulation of the expression of the components of the PA system in bovine mammary epithelial and myoepithelial cells is independent of cell type but is closely related to a speci¢c stage of the cell cycle. We also provide data indicating that as the cell cycle progresses, plasmin-speci¢c inhibitor(s) may be as critically involved in the regulation of the PA/plasminogen system as are PA inhibitors.
Materials and methods

Reagents
Cell culture media (DME-F12, RPMI 1640, NCTC-135, DMEM), HBSS, lactose, lactalbumin enzymatic hydrolysate, glutathione, L-ascorbic acid, hydrocortisone, progesterone, gentamicin, penicillin/ streptomycin/neomycin, kanamycin, trypsin, cell dissociation solution, Triton X-100, amiloride, D-ValLeu-Lys p-nitroanilide, human and bovine plasminogen were purchased from Sigma. Bovine insulin, transferrin, fetal bovine, newborn, and iron-supplemented calf sera (all heat-inactivated) were from Life Technologies (Gibco BRL). Elastase (porcine pancreas) was purchased from Calbiochem-Novabiochem. Chromogenic substrate, Spectrozyme UK, and u-PA standards were from American Diagnostica. Zeta-Probe GT nylon membranes were purchased from BioRad. Bovine u-PA and u-PAR cDNA probes were provided by Dr. J. Kra «tzschmar (Berlin, Germany). Bovine PAI-1 cDNA was a kind gift from Dr. M.S. Pepper (Geneva, Switzerland). Human PAI-2 cDNA and genomic proliferating cell nuclear antigen (PCNA) DNA were obtained from ATCC (Rockville, MD; ATCC(R) 61352 and 61054). [K-32 P]dCTP and [methyl-3 H]thymidine were purchased from Amersham. Prime IT RmT Random Primer kit was purchased from Stratagene.
Cells and culture conditions
Bovine mammary epithelial (BME-UV1, clone E-T and BME-UV, clone E-T2) and myoepithelial (BMM-UV, clone m-T2) cell lines were established in our laboratory from primary culture developed from a lactating mammary gland [22, 23] . Cells within 200^250 population doublings (100^125 passages) were employed. Epithelial cells were maintained in combined DME-F12, RPMI 1640, and NCTC-135 (2:1:1) medium and myoepithelial cells were cultured in DM-F12, RPMI 1640, NCTC-135, and DMEM (1:1:1:1) medium with di¡erent supplements as described [23^25]. Myoepithelial cells were routinely passaged using standard trypsin-EDTA (0.25% and 0.02% respectively) treatment while epithelial cells were ¢rst treated with elastase (2.5 U/ml in non-enzymatic cell dissociation solution) for 5 min at 37³C followed by regular trypsin-EDTA treatment [24] .
Determination of cell cycle phases
Growth of a subcon£uent cell layer in 24-well plates was arrested by incubation in serum-and growth factor/hormone-depleted medium for 24 h. At the end of this period, cells were washed 3 times with HBSS and renewed growth was stimulated by addition of complete growth medium. Growth-stimulated cells were pulse-labeled with [methyl-3 H]thymidine (5 WCi/ml) for 30 min. At indicated time points cells were detached. Half of the cells were used to determine [ 3 H]thymidine incorporation into DNA in terms of TCA precipitable radioactivity as described elsewhere [25] . The other half were counted using a hemocytometer. Each determination was done in triplicate.
Preparation of cell lysate
In experiments performed to determine cell-associated PA activity, bovine mammary cells were grown in 60 mm petri dishes and synchronized as described above. At speci¢c times after the initiation of synchronous growth, the cells were washed 3 times with HBSS and harvested with a rubber policeman in the presence of 0.1% Triton X-100, 0.05 M Tris-HCl, 0.15 M NaCl, pH 7.4. Cell lysates were vortexed vigorously and stored at 320³C. After centrifugation at 5000Ug for 10 min, the supernatants were used for the assays of PA and plasmin inhibitor activity. Additionally, the number of viable cells at each time point was determined by hemocytometry in the presence of Trypan blue.
Plasmin and plasminogen activator assay
PA activity in cell lysates was measured in triplicate aliquots by an assay that uses di¡erent chromogenic substrates to discriminate between u-PA-specific plasminogen activation and direct u-PA proteolytic (amidolytic) activity according to manufacturer recommendations. Plasmin activity generated in the presence of u-PA was monitored using the substrate Val-Leu-Lys p-nitroanilide while Spectrozyme was used to detect u-PA activity. To explore the possible presence of plasmin inhibitor(s), cell lysates were preincubated with plasmin and the assay was performed in the presence of plasmin-speci¢c substrate. All assays were conducted at 37³C in 96-well plates as described [10] . u-PA activity was expressed as the increase in absorbance per 60 min at V 405 nm and ¢nally was normalized to the corresponding cell number.
RNA extraction and Northern blot analysis
Subcon£uent monolayers of bovine mammary cells grown in 100 mm petri dishes were treated as described above. At speci¢c times after the initiation of synchronous growth, total RNA extraction was performed using a guanidinium thiocyanate isolation procedure. Brie£y, culture medium was aspirated and cells were lysed by the addition of 0.6 ml of solution D. Cellular lysates were collected with a rubber policeman and processed as described [26] .
Total RNA (15 Wg) was fractionated on 1% agarose gel in the presence of 2.0 M formaldehyde and blot transferred to the membrane in 10USSC (10USSC, 1.5 M NaCl, 0.15 M Na 3 Wcitrate, pH 7.0). Membranes were baked for 1 h at 80³C and subsequently UV-cross-linked. Blots were probed with u-PA, u-PAR, PAI-1, PAI-2, and PCNA specific probes labeled with [K-32 P]dCTP by the random priming technique as recommended by the manufacturer. Ethidium bromide staining and 18S cDNA reprobing were used as an internal loading and transfer controls.
Results
Duration of cell cycle
Monolayer cultures of bovine mammary myoepithelial (clone m-T2) and epithelial (clones E-T and E-T2) cells were grown to approx. 25% con£uency, after which the cells were synchronized in G 0 /G 1 by incubation in medium without serum and growth promoter supplements for 24 h. Preliminary experiments (data not shown) have con¢rmed that under these conditions approx. 95% of the cells are quiescent. After growth re-initiation, cells were pulse-labeled with [ 3 H]thymidine, and thymidine incorporation and the corresponding cell numbers were determined (Fig. 1) . The classic pattern of the progression of all three cell lines through the cell cycle is apparent, with clearly distinguishable G 1 , S, and G 2 /M phases of the cycle. The length of the complete cell cycle is approx. 18 h (m-T2), 19.5 h (E-T), and 21 h (E-T2), with G 1 , S and G 2 /M phases comprising 6^7, 7^9, and 5^6 h respectively.
Accumulation of u-PA activity during cell cycle progression
The lysates of cells synchronized throughout the cell cycle showed a consistent increase in the level of cell-associated u-PA proteolytic (amidolytic) activity, beginning immediately after growth stimulation (Fig. 2) . For all cell lines, the highest levels of activity occur at the late S/early G 2 stage of the cell cycle followed by a decrease, primarily during the late M phase. The relative accumulation of u-PA activity increases from 100% in growth-arrested cells to 170% for m-T2 cell line ( Fig. 2A) , to 205% for E-T (Fig. 2B) , and to 255% for E-T2 (Fig. 2C) and then decreases to 129%, 190%, and 186% correspondingly. As expected, the relative accumulation increases when the cells enter a new cell cycle. Despite the distinct di¡erences in the absolute values (both maximal and minimal levels) of activity detected in di¡er-ent cell lines, these data clearly indicate that the distribution of cell-associated u-PA activity within cell cycle phases is not dependent on if it is epithelial or myoepithelial cells but rather is closely associated with the order of cell cycle progression. To eliminate Fig. 2 . Cell cycle-dependent appearance of cell-associated u-PA amidolytic activity in m-T2 (A), E-T (B), and E-T2 (C) cell lysates. Growth-arrested cells were stimulated with complete medium and cell detergent extracts in triplicate were prepared at the indicated times. U-PA activity was measured spectrophotometrically using u-PA-speci¢c substrate. The data are expressed as change in absorbance/h/10 5 cells, and are normalized to the activity in quiescent cell extracts. The standard deviation of detected activity did not exceed 10% per sample (n = 3). underestimation of detected u-PA activity (in order to activate presumably existing scu-PA), cellular lysates were treated with trace amounts (0.01 U/ml) of plasmin followed by the direct assay in the presence or absence of the plasmin inhibitor aprotinin. The data (not presented) revealed that there is little or no inactive u-PA in the cell lysates we used.
Detection of plasminogen activation activity
To further characterize the modulation of u-PA activity, we tested the same cell lysates using an indirect PA assay which employs exogenously added plasminogen and the plasmin-speci¢c chromogenic substrate. Surprisingly, the time course of u-PA-speci¢c plasminogen activation activity did not re£ect the dynamics of the u-PA amidolytic activity described above. Furthermore, as observed in Fig. 3 , the appearance of u-PA-generated plasmin activity is greatly reduced as cells traverse the G 1 phase of the cell cycle remaining, for the m-T2 myoepithelial cell line (Fig. 3A) , undetectable in S and G 2 segments with a rapid increase in the M phase and thereafter.
For the E-T2 epithelial cell line (Fig. 3C) , the level of plasmin activity detected was approximately halved during S and G 2 /M phases as compared to quiescent cells with a slight increase at the beginning of the next cell cycle. Finally, the E-T epithelial cell line lysates showed a 2-fold decrease in generated plasmin activity during only the G 1 phase of the cell cycle 2 and 3 were preincubated with plasmin (0.25 U/ml) for 30 min at 37³C followed by chromogenic substrate assay with plasminspeci¢c substrate. The data are expressed as percentage of recovered activity from the activity of plasmin preincubated with lysis bu¡er. Fig. 3 . Cell cycle regulation of PA activity in m-T2 (A), E-T (B), and E-T2 (C) cell lysates. The same cell lysates as in Fig. 1 were analyzed for PA activity using indirect chromogenic substrate assay in the presence of plasminogen and plasmin-speci¢c substrate. The data were obtained and processed as in Fig. 2 and are expressed as percentage of the activity presented in cell extracts at time 0.
( Fig. 3B) with progressive increase during all subsequent stages.
Detection of plasmin inhibitor activity
In order to learn more about the involvement of plasmin inhibitor(s) activity in the regulation of the PA/plasminogen system during cell cycle progression, we employed direct plasmin assay using the same samples. This allows us to rule out any possible in£uence of PA inhibitors. In Fig. 4 , it can be clearly seen that even quiescent cell lysates contain substances capable of plasmin inhibition. Further decline in plasmin activity detected occurs for all cell lines during the G 1 phase of the cell cycle. For the m-T2 cell line (Fig. 4A) , the 2-fold decrease persists during G 1 and S phases followed by a 1.5-fold increase in G 2 /M, and ¢nally approaches a steady-state level. Similar results were observed for both epithelial cell lines except a 4-fold inhibition of plasmin activity in E-T cell lysates (Fig. 4B ) persisted into early G 2 phase while for the E-T2 cell line it was achieved at late G 1 phase of the cell cycle (Fig. 4C) . These results indicate that the inhibitory activity(ies) observed in both plasminogen activator and plasmin assays is mainly due to the presence of plasmin inhibitor(s) rather than PA inhibitor(s).
Northern blot hybridization
Northern blot analysis was performed to evaluate the modulation of u-PA, u-PAR, PAI-1 and PAI-2 mRNA transcripts during the cell cycle. Consistent with the results of the u-PA-speci¢c amidolytic assay, low u-PA mRNA levels were detected in quiescent cells (Fig. 5A ,B,C, lane 1). Increases in u-PA transcription were rapid, attained maximal level in mid-G 1 phase (3 h post stimulation for m-T2 and E-T cells and 3^6 h for the E-T2 cell line), and declined with the onset of DNA synthesis. During G 2 /M phases, the u-PA mRNA abundance approximated that of growth-arrested cells.
Similar to u-PA transcripts, the u-PAR mRNA levels were low in quiescent cells (Fig. 6A ,B,C, lane 1) for all cell lines and increased signi¢cantly within 3 h of growth stimulation (Fig. 6, lane 2) . Subsequent kinetics of the u-PAR mRNA transcript accumulation during the cell cycle were di¡erent from that of u-PA and were unique for each cell line. For the E-T epithelial cells, the u-PAR transcripts peaked at 3 h but, unlike those of u-PA mRNA, continued to be elevated at 6 and even 9 h after growth stimulation (Fig. 6B) . For the E-T2 epithelial cell line, the u-PAR mRNA abundance peaked during 6 and 9 h, and remained at the increased level even at 12 h (mid-S phase) (Fig. 6C ). For the m-T2 myoepithelial cells, the maximal increase in u-PAR transcript levels seen at 3 h (mid-G 1 ) was maintained at the same levels through 6 h (G 1 /S boundary) and 9 h (early S phase) of the cell cycle (Fig. 6A) . These results suggest that as the cell cycle progresses, the increase in u-PAR mRNA transcription is one step behind the corresponding increase in u-PA mRNA transcription.
As can be seen from Fig. 7 , the cell cycle regulation of PAI-1 mRNA transcription is very similar to that of u-PA. Again, maximal accumulation of PAI-1 mRNA in E-T and E-T2 cell lines occurred at 3 h and 3^6 h after growth stimulation respectively (Fig.  7B,C) . The m-T2 myoepithelial cells di¡ered somewhat in that the PAI-1 mRNA levels were equally elevated from 3 to 9 h after initiation of growth cycle (Fig. 7A ) while u-PA transcript clearly peaked at 3 h (Fig. 5A) . The PAI-2 mRNA transcripts in quiescent cells were at very low levels (Fig. 8) . As expected, growth stimulation triggered the increase in PAI-2 mRNA transcription. Maximal induction was detected in early G 1 phase of the cell cycle for m-T2 cells and during early/late G 1 for E-T cells. We did not ¢nd any detectable levels of PAI-2 transcripts in the E-T2 cell line.
In order to ascertain cell cycle position, the membranes were hybridized with a PCNA (a co-factor of DNA polymerase N also known as cyclin) probe. In agreement with a previous report [27] , cyclin mRNA expression was undetectable in growth-arrested cells. Appearance of PCNA transcripts was ¢rst observed during G 1 /S transition (Fig. 9) , reached a maximum during the S phase, and rapidly decreased at the end of the S phase.
Taken collectively, these results raised the possibility that during the cell cycle the di¡erent components of the PA system are regulated in a concerted manner.
Discussion
In this study we investigated the cell cycle-speci¢c variation of cell-associated u-PA activity and, in parallel, the expression of transcripts of u-PA and other components of the PA system in established bovine mammary epithelial and myoepithelial cell lines. Our results demonstrate that the biosynthesis and appearance of u-PA-speci¢c activity are highly regulated by the stage of the cell cycle. Direct u-PA amidolytic assay reveals that quiescent bovine mammary cells start to increase steady-state levels of cell-associated u-PA activity immediately after mitogenic stimulation ( Fig. 2) with maximal accumulation within the late S/early G 2 stage, falling during G 2 /M phase. While the magnitude varied somewhat, all cell lines showed a very similar pattern of the distribution of PA activity in corresponding phases of the cell cycle. Aggeler et al. [19] using ¢brinolytic assay found that cell-associated PA peaked at the late S phase in Chinese hamster ovary cells (CHO) with a great reduction during G 2 /M. Human alveolar epithelial cells (A549) also produce high levels of PA at S/G 2 transition [18] , while rat hepatoma cells (ZHC) show maximum cell-associated PA activity at the very beginning of the S phase [19] . In these studies, however, the accumulation of PA during the G 1 phase was not recorded.
Since the indirect PA assay in the presence of plasminogen is estimated to be 10^1000-fold more sensitive than the direct assay, we used this test to reprobe the same samples. Surprisingly, the results obtained with indirect PA assay con£icted with the data from direct PA assay. No increase in plasminogen activation activity was observed during the G 1 phase of the cell cycle that we anticipated because of the increase in PA activity. On the contrary, we detected a strong (40^100%) decrease of plasminogen activation as compared to quiescent cell lysates. In addition, the overall pro¢le of plasminogen activation was unique for each cell line. Namely, the m-T2 myoepithelial cells showed the greatest decrease during early G 1 , falling to undetectable levels during S and G 2 stages with subsequent increase in M phase. The E-T epithelial cells showed reduced (50% decrease) plasminogen activation activity only during G 1 phase followed by a constant increase thereafter. Finally, E-T2 epithelial cells showed a decrease of plasminogen activation through all phases of the cell cycle with only a small increase as the next cycle began. These results can only be explained by the presence of increasing amounts of PA and/or plasmin inhibitors. In this regard, the fact that the amidolytic activity of u-PA detected in the direct PA assay was una¡ected may indicate that the corresponding inhibitors are present in non-active, or latent forms. Indeed, recent structural studies on PAI-1 [28, 29] , PAI-2 [30, 31] , and protein C inhibitor (PAI-3) [32] have shown that these inhibitors occur in both active and latent conformations which may be activated by plasmin generated from plasminogen in the presence of u-PA. Furthermore, PAI-2 has been characterized as a predominantly intracellular inhibitor whose physiological intracellular function is as yet uncertain [30, 33] . Latent conformations of plasmin-speci¢c inhibitors which can be proteolytically activated have also been described for K 2 -macroglobulin [34] , inter-K-trypsin inhibitor [35] , and urinary trypsin inhibitor/bikunin [36] .
To separate the e¡ect of PAIs and plasmin inhibitors, we included a colorimetric assay in which active plasmin was preincubated with the cell lysate samples. If the activation of latent PAIs was a key in£uence on the results of the indirect PA assay, the direct plasmin assay would reveal no di¡erences in recorded activity. However, plasmin assay showed that for all cell lines tested the role of plasmin inhibitors is important at least during the G 1 and S phases (Fig. 4) . According to our preliminary data (not shown) one of these inhibitors is urinary trypsin inhibitor/bikunin. Further evaluation and quantitation of the data obtained with all three cell lines reveal that plasmin inhibitors play a central role in the PA/ plasminogen system regulation during the cell cycle. This conclusion raises the question of the role of u-PA in the progression through the cell cycle. If the role is solely to activate plasminogen, then it would be logical to control the very early steps of the ampli¢cation loop, i.e., plasminogen activation. This seems not to be the case since, during G 1 and S phases of the cell cycle, cell-associated u-PA activity progressively increases while u-PA-generated plasmin activity is strongly suppressed. It is tempting to speculate that during cell cycle progression u-PA may have targets other than plasminogen activation. These might include the activation of other latent proteases, plasmin-independent proteolytic processing of other proteins including growth factor activation [37, 38] , or a direct function as a growth factor due to the presence within the u-PA molecule of a growth factor-like domain [39] . Interestingly, the decrease in plasmin inhibitory activity detected during G 2 /M phases coincides with reduced levels of cellassociated u-PA activity. Since others have described an increased appearance of secreted PA in cell-conditioned medium during this stage of the cell cycle [19, 40] , it may be that mitotic cells use the PA/plasminogen system in order to disrupt their association with the extracellular matrix allowing cell division. On the basis of these results, it is constructive to speculate that extracellular proteolysis during mitotic division is mainly governed by secreted free u-PA while focalized cell surface-associated u-PA is more involved in pericellular proteolysis (or other activities) during the S phase of the cell cycle.
A second group of experiments provides intriguing data. Based upon Northern blot hybridization, it can be concluded that the maximum transcription of the u-PA gene is restricted to a short`window' in mid-to late G 1 phase (3^6 h after growth stimulation) of the cell cycle (Fig. 5) . The highest levels of cell-associated u-PA activity, however, are found at S/G 2 boundary or early G 2 stage (9^12 h later) when the u-PA mRNA level is approximately that of quiescent cells. The physiological signi¢cance of such a delay between maximal transcription and the appearance of active protein is as yet unclear. In contrast, the present study and earlier reports [27, 41] showed that the maximal expression of cell cycle-dependent PCNA (both at mRNA and protein levels) occurs during the S phase. Resembling the pattern of u-PA mRNA appearance, the u-PAR, PAI-1, and PAI-2 mRNA transcripts also peaked early in the G 1 phase. Similar cell cycle-dependent accumulation of PAI-1 and PAI-2 transcripts (mid-G 1 phase) has been described in previous reports [16, 17, 42, 43] . None of these studies, however, described the cell cycle regulation of u-PA and u-PAR transcripts or the modulation of u-PA activity. Since the majority of total cell-associated u-PA in bovine mammary cells is presented as membrane receptor-bound activity [21] , the concurrent modulation of u-PA, u-PAR, PAI-1, and PAI-2 should lead to the modulation of detected extracellular u-PA activity during the cell cycle. The delay between maximum transcription and the maximum activity of cell-associated u-PA may be due to posttranscriptional regulation. Alternatively, during initial stages of the cell cycle u-PA (alone or complexed with PAIs and/or u-PAR) may have non-proteolytic functions.
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